Draxxin-V-C-0077-II-0031: EPAR - Assessment Report - Variation
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Source
European Medicines Agency
Additional Information
medication.label.product_type
variation-report
medication.label.permit_number
EMA/150039/2016
medication.label.permit_validity
First published: 2016-06-02T02:00:00Z
Documents
Related Medications
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
AI Voice
Listen to the article content live